Home › Quanterix' Simoa Technology To Broaden RayBiotech Immunoassay Services
 

Keywords :   


Quanterix' Simoa Technology To Broaden RayBiotech Immunoassay Services

2015-04-01 07:41:59| drugdiscoveryonline Home Page

Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, recently announced that RayBiotech, Inc., of Norcross, GA, has adopted its Simoa technology to deploy as part of their innovative solutions for biomarker discovery and testing

Tags: services technology broaden immunoassay

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
25.09Shein should come to London says former B&Q boss
25.09China probes Calvin Klein over Xinjiang cotton
25.09Huel hit with third ad ban in two months
25.09Atlantic Tropical Weather Outlook
25.09Tropical Storm Helene Public Advisory Number 7A
25.09Summary for Tropical Storm Helene (AT4/AL092024)
25.09Eastern North Pacific Tropical Weather Outlook
25.09Sickness benefit claimants should look for work - PM
More »